|1.||Pemphigus (Pemphigus Vulgaris)
|2.||Bullous Pemphigoid (Pemphigoid)
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
|5.||Dermatitis Herpetiformis (Disease, Duhring's)
|1.||Hashimoto, Takashi: 85 articles (11/2015 - 03/2002)|
|2.||Zillikens, Detlef: 71 articles (10/2015 - 01/2002)|
|3.||Schmidt, Enno: 41 articles (09/2015 - 01/2002)|
|4.||Zillikens, D: 38 articles (04/2014 - 01/2000)|
|5.||Ishii, Norito: 35 articles (10/2015 - 01/2006)|
|6.||Hashimoto, T: 35 articles (12/2014 - 01/2000)|
|7.||Sitaru, Cassian: 33 articles (02/2015 - 01/2002)|
|8.||Koga, Hiroshi: 28 articles (11/2015 - 02/2009)|
|9.||Schmidt, E: 22 articles (04/2014 - 01/2000)|
|10.||Wojnarowska, F: 20 articles (07/2015 - 02/2000)|
|1.||Adrenal Cortex Hormones (Corticosteroids)IBA
03/01/2004 - "To evaluate the efficacy of potent class I topical corticosteroids in relation to the affected body surface area (BSA) in patients with bullous pemphigoid and to review the literature. "
05/01/2009 - "Since high doses of superpotent topical corticosteroids (CS) have been shown to improve the survival of bullous pemphigoid (BP) patients and to be more effective than oral CS, few studies have described the long-term course of the disease of these patients. "
06/01/2009 - "Histopathological, immunological and serological data confirmed the diagnosis of localized bullous pemphigoid (BP) and treatment with systemic and local corticosteroids led to a sustained remission. "
03/01/2004 - "A dozen reports were published regarding the efficacy of topical corticosteroids in the treatment of bullous pemphigoid. "
01/01/2004 - "In spite of the introduction of systemic corticosteroids, the mortality rates in bullous pemphigoid have generally not improved and vary between 0% and 40%. "
|2.||mycophenolate mofetil (Cellcept)FDA LinkGeneric
09/01/1998 - "Successful therapy for bullous pemphigoid with mycophenolate mofetil."
12/01/2013 - "[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)]."
09/01/2010 - "We report a 16-year-old girl with bullous pemphigoid who achieved disease remission with mycophenolate mofetil as an adjuvant therapy."
01/01/2015 - "Mycophenolate mofetil therapy for pediatric bullous pemphigoid."
06/01/2013 - "To evaluate the clinical outcomes of mycophenolate mofetil (MMF) treatment of mucous membrane pemphigoid (MMP). "
10/01/1985 - "The highly specific binding of bullous pemphigoid autoantibodies to the hemidesmosome may prove helpful in future biochemical and immunocytochemical studies of this organelle."
04/01/2014 - "Therefore, we addressed in the present study the role of autoantibodies to BP230 in experimental bullous pemphigoid. "
10/01/2006 - "By contrast, the titres of autoantibodies against BP180 in the serum and saliva of bullous pemphigoid patients were not statistically related, and further study of the usefulness of the BP180 ELISA for saliva in this disease is needed. "
01/01/1996 - "In an earlier study, the circulating autoantibodies in patients with bullous pemphigoid (BP) were demonstrated in higher frequencies by means of an immunoblot technique then via indirect immunofluorescence. "
06/01/1993 - "The purpose of the present study was to determine whether tissue-bound anti-basement membrane zone (BMZ) autoantibodies in patients with bullous pemphigoid (BP) express a cross-reactive idiotype. "
06/01/1995 - "We have recently developed a novel immunoblotting system using bacterial fusion protein containing the NC16a domain, the most immunogenic region, of the 180 kD bullous pemphigoid (BP) antigen, which was shown to be highly sensitive and specific method to detect the antigen and to be very useful for the diagnosis of BP. In this study, using this immunoblot assay, we investigated sera obtained from 26 patients who showed atypical clinical features. "
03/01/2013 - "A common Human Leukocyte Antigen (HLA) class II allele, DQβ1*03:01, seems to be associated with Bullous pemphigoid (BP) in Caucasians whereas previous studies in other ethnic groups showed other HLA class II alleles as genetic predisposing factors for BP. To investigate the association of HLA class II alleles and haplotypes with BP in Iranian population. "
06/01/2004 - "Our data provide further information of the porcine bullous pemphigoid target antigen and may help investigators for their further studies of this disease."
04/01/2004 - "The aim of this study was to analyze the relationship between clinical features of bullous pemphigoid patients and the antigens recognized by their serum. "
11/01/2000 - "The purpose of this study was to clarify the precise in vivo structure of the 180 kDa bullous pemphigoid antigen in normal human skin. "
01/01/2005 - "Very potent topical steroids are effective and safe treatments for bullous pemphigoid; their use in extensive disease may be limited by side effects and practical factors. "
01/01/2003 - "Very potent topical steroids are effective and safe treatments for bullous pemphigoid; their use in extensive disease may be limited by side effects and practical factors. "
01/01/2011 - "The efficacy of topical steroids in bullous pemphigoid (BP) was assessed by prospective therapeutic trials. "
12/01/2011 - "The interest of long-term superpotent topical steroids (STS) in bullous pemphigoid (BP) has been supported by randomized controlled trials. "
07/01/2014 - "There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids). "
|6.||Prednisolone (Predate)FDA LinkGeneric
05/18/1985 - "This study suggests that a combined treatment with moderate doses of prednisolone and 4 large volume plasma exchanges is well tolerated and highly effective in bullous pemphigoid."
04/01/2001 - "The skin lesion of pemphigoid was improved after increasing the prednisolone dose up to 60 mg a day."
03/01/2006 - "He was next diagnosed as suffering from bullous pemphigoid and treated with oral prednisolone, which worsened his condition. "
05/01/2004 - "We studied the precise correlation between ELISA values for BP180 NC16A and the alternations of disease activity in 5 patients with bullous pemphigoid (BP) during various treatments and tried to answer the question of how we can use ELISA to determine the timing of prednisolone (PSL) tapering. "
01/01/1984 - "[Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. "
|7.||Azathioprine (Imuran)FDA LinkGeneric
05/01/2006 - "Thus, Cy-A is an useful treatment for ocular chronic autoimmune pemphigoid and eventually azathioprine (50 mg/day) can cheaply replace it although its well-known toxicity."
07/01/1978 - "A controlled trial of azathioprine in the treatment of pemphigoid [proceedings]."
04/01/2000 - "We report a case of a patient with bullous pemphigoid who experienced azathioprine-induced myelosuppression and who was later found to be homozygous for TPMT mutant alleles. "
02/01/1974 - "Azathioprine in the treatment of muco-cutaneous pemphigoid."
01/16/1971 - "Thus azathioprine is valuable in long-term management of pemphigoid, particularly in patients showing corticosteroid toxicity or in whom the minimum maintenance dose is dangerously high."
|8.||Methotrexate (Mexate)FDA LinkGeneric
05/01/2008 - "Methotrexate is an effective and safe drug and provides an excellent treatment option in patients with bullous pemphigoid."
10/01/1994 - "The aim of this study was to evaluate the efficacy of low-dose methotrexate as a steroid-sparing agent in patients with bullous pemphigoid. "
11/01/2003 - "Methotrexate for bullous pemphigoid: preliminary study."
05/01/1999 - "Our study suggests that low-dose oral pulse methotrexate constitutes an effective therapeutic alternative in elderly patients with generalized bullous pemphigoid."
11/01/2014 - "Methotrexate as a treatment in ocular cicatricial moderate pemphigoid."
|9.||Niacinamide (Nicotinamide)FDA LinkGeneric
04/01/2006 - "These results suggest that nicotinamide, which has been used in humans for the treatment of diabetes and bullous pemphigoid, may hold promise as a preventive therapy of FAS."
08/01/1998 - "This is the first report, to our knowledge, of a case of bullous pemphigoid responding to niacinamide alone."
08/01/1998 - "A case of bullous pemphigoid responding to niacinamide as monotherapy is reported. "
11/01/1991 - "Niacinamide for bullous pemphigoid."
06/01/1994 - "The combination of nicotinamide and tetracycline has been anecdotally reported to be effective in the treatment of bullous pemphigoid. "
|10.||Tetracycline (Achromycin)FDA LinkGeneric
01/01/1995 - "Generalized bullous pemphigoid controlled by tetracycline therapy alone."
02/01/1994 - "Treatment of generalized bullous pemphigoid with oral tetracycline."
01/01/1994 - "Treatment of generalized bullous pemphigoid with oral tetracycline."
02/01/1987 - "Two men with nonscarring, persistent, localized bullous pemphigoid, whose eruption is completely controlled with daily doses of oral tetracycline, are described. "
02/01/1987 - "Bullous pemphigoid controlled by tetracycline."
09/01/1984 - "41 patients with pemphigoid entered a multicentre randomised study of the efficacy of plasma exchange. "
01/01/1986 - "Long term plasma exchange therapy in bullous pemphigoid."
11/01/1985 - "[Plasma exchange and corticosteroid therapy in the treatment of bullous pemphigoid]."
09/01/1984 - "Plasma exchange in bullous pemphigoid."
09/03/1983 - "[Bullous pemphigoid treated by plasma exchange. "
04/01/2014 - "Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature."
04/01/2003 - "We report a case of bullous pemphigoid successfully treated with double filtration plasmapheresis. "
12/01/2001 - "Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report."
03/01/2001 - "A case of severe bullous pemphigoid treated with plasmapheresis."
03/01/2000 - "Due to its high cost and potential morbidity, plasmapheresis should not be recommended as routine therapy for bullous pemphigoid, but it is a useful adjunct in resistant cases."
|3.||Transplantation (Transplant Recipients)
08/01/2015 - "Bullous pemphigoid induced by m-TOR inhibitors in renal transplant recipients."
05/01/2014 - "Bullous pemphigoid in a renal transplant recipient."
04/01/2012 - "Bullous pemphigoid eleven years after bilateral hand transplantation."
01/01/2009 - "Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature."
05/01/1997 - "After separation of symblepharons in ocular pemphigoid, transplantation of nasal or bucal mucosa is recommended to prevent recurrent lid fusion; however, it is not always successful. "
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/01/1986 - "Development of bullous pemphigoid after allogeneic bone marrow transplantation. "
01/01/2006 - "Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation."
10/01/1992 - "Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation."
01/01/2006 - "We present two patients who developed keratitis sicca and pemphigoid-like symptoms following allogeneic bone marrow transplantation (BMT). "
01/01/2005 - "We present two cases of patients who developed keratitis sicca (dry eyes) and pemphigoid-like symptoms after allogeneic bone marrow transplantation. "
11/01/2004 - "Immunomodulatory therapy has provided an avenue for preserving vision and preventing potentially fatal consequences of systemic pemphigoid. "
11/01/2006 - "Immunomodulatory therapy may positively influence shared as well as distinct inflammatory mechanisms in patients who have psoriasis and bullous pemphigoid."
11/01/2004 - "To report the case of a patient developing fungal keratitis in the context of uncontrolled ocular cicatricial pemphigoid (OCP), which, despite intravenous immunoglobulin (IVIg) and other immunomodulatory therapy, progressed to end-stage pemphigoid, with corneal opacification, ankyloblepharon, and xerosis. "
01/01/1987 - "Due to its influence on dermal inflammatory processes and immunomodulation of the tissue response, etretinate is effective in cutaneous lupus erythematosus, certain bullous disorders like pemphigus herpetiformis, the persistent variant of Grover's disease, dermatitis herpetiformis, and bullous pemphigoid. "